stella
beta
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma — Stella
Recruiting
Back to T-Cell Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
Yale Smilow Cancer Hospital, New Haven, Connecticut
Dana Farber Cancer Institute, Boston, Massachusetts
View full record on ClinicalTrials.gov